CUCCHIARA, VITO
 Distribuzione geografica
Continente #
EU - Europa 1.387
NA - Nord America 891
AS - Asia 794
SA - Sud America 128
AF - Africa 17
OC - Oceania 2
Totale 3.219
Nazione #
US - Stati Uniti d'America 851
RU - Federazione Russa 781
SG - Singapore 277
CN - Cina 250
IT - Italia 227
BR - Brasile 99
HK - Hong Kong 96
SE - Svezia 80
VN - Vietnam 77
DE - Germania 73
FI - Finlandia 47
FR - Francia 47
GB - Regno Unito 39
IN - India 27
CA - Canada 24
NL - Olanda 24
ES - Italia 15
MX - Messico 14
AR - Argentina 12
JP - Giappone 12
PL - Polonia 12
AT - Austria 9
BD - Bangladesh 9
PK - Pakistan 8
TR - Turchia 8
ZA - Sudafrica 8
BE - Belgio 6
EC - Ecuador 6
IQ - Iraq 4
LT - Lituania 4
NO - Norvegia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IE - Irlanda 3
IL - Israele 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
DZ - Algeria 2
KE - Kenya 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.219
Città #
Dallas 181
Singapore 181
Moscow 148
Ashburn 127
Hong Kong 94
Milan 85
San Jose 79
New York 68
Beijing 50
Shanghai 46
Los Angeles 34
Ho Chi Minh City 31
Munich 30
Hefei 29
Lauterbourg 28
Turku 26
Orem 23
Boardman 20
Hanoi 17
Princeton 16
Lawrence 15
Helsinki 14
Chennai 13
Frankfurt am Main 13
Nuremberg 13
Santa Clara 13
Rome 12
São Paulo 12
Montreal 11
London 9
Amsterdam 8
Brooklyn 8
Manchester 8
Warsaw 8
Bologna 7
Denver 7
Stockholm 7
Ankara 6
Da Nang 6
Lappeenranta 6
Phoenix 6
Rho 6
San Diego 6
Tokyo 6
Valencia 6
Cesano Boscone 5
Chicago 5
Columbus 5
Johannesburg 5
Mexico City 5
San Francisco 5
The Dalles 5
Turin 5
Vienna 5
Bexley 4
Brussels 4
Buffalo 4
Houston 4
Macerata 4
Oslo 4
Poplar 4
Pune 4
Querétaro 4
Reston 4
Aci Sant'antonio 3
Athens 3
Atlanta 3
Barnet 3
Bauru 3
Birmingham 3
Brasília 3
Dublin 3
Falkenstein 3
Fortaleza 3
Guayaquil 3
Manassas 3
Milwaukee 3
Novara 3
Ottawa 3
Paderborn 3
Romagnano Sesia 3
Seattle 3
Tianjin 3
Zhengzhou 3
Baie-D'Urfé 2
Belfast 2
Belo Horizonte 2
Bergamo 2
Bethesda 2
Boston 2
Bratislava 2
Brescia 2
Campinas 2
Carapicuíba 2
Caxias do Sul 2
Cerano 2
Chula Vista 2
Council Bluffs 2
Dhaka 2
Florence 2
Totale 1.716
Nome #
IL RUOLO DELLE CELLULE T DI MEMORIA RESIDENTI NEI TESSUTI NEL TUMORE PROSTATICO: IMPLICAZIONI PER GLI ESITI ONCOLOGICI 244
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 155
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 151
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 139
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 134
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 121
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 120
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 119
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 110
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 108
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 108
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 107
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 104
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 101
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 101
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 97
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 94
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 93
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 91
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 91
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 88
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 81
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 78
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 70
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 64
SINGLE NUCLEOTIDE POLYMORPHISMS AND RISK OF PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL GENETIC RISK SCORE FOR INDIVIDUALIZED SCREENING AND DIAGNOSTIC PROGRAMMES 36
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 36
null 23
SARS-CoV-2 genomic surveillance of migrants arriving to Europe through the Mediterranean routes 1
Totale 3.291
Categoria #
all - tutte 13.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 9 2 7 2 3 3 3 0 0 0 3
2022/2023143 39 28 11 13 4 15 5 12 4 3 2 7
2023/2024219 3 18 23 17 18 49 3 20 0 16 17 35
2024/2025697 48 26 32 25 49 50 115 95 83 42 63 69
2025/20262.199 159 141 162 270 200 76 195 208 675 113 0 0
Totale 3.291